AXOGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.63 USD | +1.69% |
|
+2.00% | -2.93% |
| Mar. 08 | Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing | MT |
| Mar. 08 | AxoGen, Inc. Announces Executive Changes | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 706.1 | 718.3 | 389.4 | 422 | 294 | 289.8 | - | - |
| Enterprise Value (EV) 1 | 706.1 | 718.3 | 389.4 | 422 | 294 | 289.8 | 289.8 | 289.8 |
| P/E ratio | -24.2 x | -29.8 x | -14.4 x | -14.5 x | -13.4 x | -15.4 x | -199 x | 24.1 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 6.62 x | 6.4 x | 3.06 x | 3.05 x | 1.85 x | 1.62 x | 1.44 x | 1.29 x |
| EV / Revenue | 6.62 x | 6.4 x | 3.06 x | 3.05 x | 1.85 x | 1.62 x | 1.44 x | 1.29 x |
| EV / EBITDA | -23.2 x | -33.3 x | -19.5 x | -45.6 x | -262 x | 28 x | 12.4 x | 6.95 x |
| EV / FCF | - | - | - | -11.7 x | -15 x | -18.2 x | 18.5 x | 12.6 x |
| FCF Yield | - | - | - | -8.56% | -6.66% | -5.49% | 5.42% | 7.94% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 39,469 | 40,126 | 41,563 | 42,287 | 43,044 | 43,705 | - | - |
| Reference price 2 | 17.89 | 17.90 | 9.370 | 9.980 | 6.830 | 6.630 | 6.630 | 6.630 |
| Announcement Date | 2/24/20 | 2/22/21 | 2/22/22 | 3/14/23 | 3/5/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 106.7 | 112.3 | 127.4 | 138.6 | 159 | 179.3 | 201.4 | 225.1 |
| EBITDA 1 | -30.47 | -21.6 | -19.94 | -9.259 | -1.12 | 10.33 | 23.31 | 41.7 |
| EBIT 1 | -31.41 | -23.18 | -25.42 | -29.71 | -21.46 | -15.6 | 3.167 | 33 |
| Operating Margin | -29.43% | -20.64% | -19.96% | -21.44% | -13.5% | -8.7% | 1.57% | 14.66% |
| Earnings before Tax (EBT) 1 | -29.14 | -23.79 | -26.98 | -28.95 | -21.72 | -17.95 | 0.917 | 31.6 |
| Net income 1 | -29.14 | -23.79 | -26.98 | -28.95 | -21.72 | -18.63 | -1.622 | 12.1 |
| Net margin | -27.3% | -21.18% | -21.19% | -20.89% | -13.66% | -10.39% | -0.81% | 5.37% |
| EPS 2 | -0.7400 | -0.6000 | -0.6500 | -0.6900 | -0.5100 | -0.4300 | -0.0333 | 0.2750 |
| Free Cash Flow 1 | - | - | - | -36.14 | -19.59 | -15.9 | 15.7 | 23 |
| FCF margin | - | - | - | -26.08% | -12.32% | -8.87% | 7.79% | 10.22% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 67.36% | 55.16% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | 190.08% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/24/20 | 2/22/21 | 2/22/22 | 3/14/23 | 3/5/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 31.2 | 31.54 | 31.01 | 34.45 | 36.96 | 36.16 | 36.66 | 38.16 | 41.27 | 42.92 | 42.05 | 43.57 | 46.11 | 47.53 | 46.4 |
| EBITDA 1 | -6.035 | -3.669 | -7.357 | -1.587 | 0.368 | -0.683 | -3.79 | -0.246 | 2.354 | 0.567 | -0.4685 | 2.324 | 4.026 | 4.454 | - |
| EBIT 1 | -6.689 | -5.353 | -11.32 | -7.924 | -4.855 | -5.608 | -7.341 | -6.902 | -4.025 | -3.194 | -5.69 | -4.548 | -3.046 | -2.318 | - |
| Operating Margin | -21.44% | -16.97% | -36.51% | -23% | -13.14% | -15.51% | -20.02% | -18.09% | -9.75% | -7.44% | -13.53% | -10.44% | -6.61% | -4.88% | - |
| Earnings before Tax (EBT) 1 | -7.141 | -5.286 | -11.48 | -7.74 | -4.318 | -5.415 | -7.074 | -6.66 | -4.089 | -3.893 | -6.24 | -5.098 | -3.646 | -2.968 | - |
| Net income 1 | -7.141 | -5.286 | -11.48 | -7.74 | -4.318 | -5.415 | -7.074 | -6.66 | -4.089 | -3.893 | -5.993 | -5.265 | -4.064 | -3.312 | - |
| Net margin | -22.88% | -16.76% | -37.01% | -22.46% | -11.68% | -14.97% | -19.29% | -17.46% | -9.91% | -9.07% | -14.25% | -12.09% | -8.81% | -6.97% | - |
| EPS 2 | -0.1700 | -0.1300 | -0.2700 | -0.1800 | -0.1000 | -0.1300 | -0.1700 | -0.1600 | -0.1000 | -0.0900 | -0.1400 | -0.1233 | -0.0933 | -0.0767 | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/3/21 | 2/22/22 | 5/4/22 | 8/3/22 | 11/8/22 | 3/14/23 | 5/9/23 | 8/7/23 | 11/7/23 | 3/5/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | -36.1 | -19.6 | -15.9 | 15.7 | 23 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 21.9 | 27.8 | 20.1 | 13.9 | 5 | 5 | 5 |
| Capex / Sales | - | 19.51% | 21.84% | 14.49% | 8.72% | 2.79% | 2.48% | 2.22% |
| Announcement Date | 2/24/20 | 2/22/21 | 2/22/22 | 3/14/23 | 3/5/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
6.63
USD
Average target price
13.8
USD
Spread / Average Target
+108.14%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.93% | 290M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
- Stock Market
- Equities
- AXGN Stock
- Financials AxoGen, Inc.
